Department of Urology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
J Sex Med. 2023 Aug 25;20(9):1153-1160. doi: 10.1093/jsxmed/qdad093.
Hypoandrogenism is a cause of erectile dysfunction (ED). Vascular smooth muscle cell contraction and relaxation are regulated by TRPV1-4 channels. However, the influence of hypoandrogenism on TRPV1-4 and its relationship with erectile function remain unclear.
To reveal whether hypoandrogenism affects erectile function by influencing TRPV1-4 expression in the corpus cavernosum of rats.
Male Sprague-Dawley rats (N = 36) aged 8 weeks were assigned to 6 groups at random (n = 6): sham operation, castrated, castrated + testosterone replacement, sham operation + transfection, castrated + transfection, and castrated + empty transfection. Four weeks after castration, 20 μL of lentiviral vector (1 × 108 TU/mL) carrying the TRPV4 gene was injected into the penile cavernous tissue of the transfection groups. One week after transfection, the maximum intracavernous pressure (ICPmax)/mean arterial pressure (MAP) and the content of TRPV1-4, phosphorylated eNOS (p-eNOS)/eNOS, and nitric oxide (NO) in penile cavernous tissue of each group were measured.
Under low androgen conditions, TRPV4 expression in endothelial cells in the rat penile cavernosum was sharply reduced, resulting in a decrease in p-eNOS/eNOS and NO content, which could inhibit erectile function.
In rat penile cavernous tissue, TRPV1-4 was expressed in the cell membranes of endothelial cells and smooth muscle cells. The ICPmax/MAP and the content of TRPV4, p-eNOS/eNOS, and NO end product nitrite level in rat penile cavernous tissue was markedly reduced in the castrated group as compared with the sham group (P < .05). The ICPmax/MAP and the content of TRPV4, p-eNOS/eNOS, and NO end product nitrite level in rat penile cavernous tissue were markedly improved in the castrated + transfection group vs the castrated group (P < .01).
Upregulation of TRPV4 expression in penile cavernosum tissue might be a viable therapeutic for ED caused by hypoandrogenism.
The specific mechanism of TRPV4 in ED needs to be further verified by androgen receptor or TRPV4 gene knockout experiments.
Hypoandrogenism may cause ED by reducing the expression of TRPV4 in rat penile cavernous tissue. Upregulation of TRPV4 expression in penile cavernous tissue can increase the ratio of p-eNOS/eNOS and NO levels and ameliorate the erectile function of castrated rats.
低雄激素血症是勃起功能障碍(ED)的一个原因。TRPV1-4 通道调节血管平滑肌细胞的收缩和舒张。然而,低雄激素血症对 TRPV1-4 的影响及其与勃起功能的关系尚不清楚。
揭示低雄激素血症是否通过影响大鼠海绵体组织中 TRPV1-4 的表达来影响勃起功能。
将 36 只 8 周龄雄性 Sprague-Dawley 大鼠随机分为 6 组(n=6):假手术、去势、去势+睾酮替代、假手术+转染、去势+转染和去势+空转染。去势 4 周后,将携带 TRPV4 基因的慢病毒载体(1×108 TU/mL)20μL 注入转染组的阴茎海绵体组织中。转染后 1 周,测量各组阴茎海绵体组织中的最大阴茎海绵体内压(ICPmax)/平均动脉压(MAP)和 TRPV1-4、磷酸化 eNOS(p-eNOS)/eNOS 及一氧化氮(NO)含量。
在低雄激素条件下,大鼠阴茎海绵体组织内皮细胞中 TRPV4 表达明显减少,导致 p-eNOS/eNOS 和 NO 含量减少,从而抑制勃起功能。
在大鼠阴茎海绵体组织中,TRPV1-4 表达于内皮细胞和平滑肌细胞膜上。与假手术组相比,去势组大鼠阴茎海绵体组织中 TRPV1-4、p-eNOS/eNOS 和 NO 终产物亚硝酸盐水平明显降低(P<0.05)。与去势组相比,去势+转染组大鼠阴茎海绵体组织中 ICPmax/MAP 和 TRPV4、p-eNOS/eNOS 和 NO 终产物亚硝酸盐水平明显升高(P<0.01)。
上调阴茎海绵体组织中 TRPV4 的表达可能是治疗低雄激素血症引起的 ED 的一种可行方法。
TRPV4 在 ED 中的具体机制需要通过雄激素受体或 TRPV4 基因敲除实验进一步验证。
低雄激素血症可能通过降低大鼠阴茎海绵体组织中 TRPV4 的表达引起 ED。上调阴茎海绵体组织中 TRPV4 的表达可增加 p-eNOS/eNOS 比值和 NO 水平,改善去势大鼠的勃起功能。